At a glance
- Originator Meiji Seika Kaisha
- Class Antidepressants; Anxiolytics; Sleep disorder therapies; Small molecules
- Mechanism of Action Serotonin 7 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sleep disorders
Most Recent Events
- 10 Nov 2006 Discontinued - Preclinical for Sleep disorders in Japan (unspecified route)
- 07 Jun 2001 No-Development-Reported for Sleep disorders in Japan (Unknown route)
- 08 Dec 1998 New profile